Need the most up-to-date news on prehospital field operations, staffing, training, management and provider safety? Catch up on the latest industry news on EMS1.

177Lu-PNT6555 is under clinical development by Eli Lilly and Co and currently in Phase I for Esophageal Squamous Cell Carcinoma (ESCC). According to GlobalData, Phase I drugs for Esophageal Squamous ...

No other corporate actions details are available.